Matches in Nanopublications for { ?s ?p "[The role of KRAS mutations in predicting the efficacy of cetuximab-plus-irinotecan therapy in irinotecan-refractory Korean metastatic colorectal cancer patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- NP156086.RAANuptzC4axqKVso2YyGHfMgKXunr3wWNY_DRVNlZC0Q130_assertion description "[The role of KRAS mutations in predicting the efficacy of cetuximab-plus-irinotecan therapy in irinotecan-refractory Korean metastatic colorectal cancer patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP156086.RAANuptzC4axqKVso2YyGHfMgKXunr3wWNY_DRVNlZC0Q130_provenance.
- assertion description "[The role of KRAS mutations in predicting the efficacy of cetuximab-plus-irinotecan therapy in irinotecan-refractory Korean metastatic colorectal cancer patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP156087.RAezrirUil7ETiHvL4tgUsrMlpdPcguXcIpweAKVBcHXM130_assertion description "[The role of KRAS mutations in predicting the efficacy of cetuximab-plus-irinotecan therapy in irinotecan-refractory Korean metastatic colorectal cancer patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP156087.RAezrirUil7ETiHvL4tgUsrMlpdPcguXcIpweAKVBcHXM130_provenance.
- assertion description "[The role of KRAS mutations in predicting the efficacy of cetuximab-plus-irinotecan therapy in irinotecan-refractory Korean metastatic colorectal cancer patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.